Baseline characteristics of study patients
| Total (n = 213) | Troponin T ⩾0.10 μg/l (n = 92) | ⩾1 ST-VM episode (n = 69) | |
|---|---|---|---|
| Between group comparisons p⩾0.05. | |||
| *p<0.05 compared with the total group; †p<0.05 compared with troponin T ⩾0.10 μg/l group and with the total group. | |||
| IQR, interquartile range; MI, myocardial infarction; ST-VM, ST vector magnitude. | |||
| Male sex | 146 (69%) | 69 (75%) | 44 (64%) |
| Age ⩾65 years | 92 (43%) | 46 (50%) | 39 (57%) |
| Smoking (past or current) | 128 (60%) | 62 (67%) | 40 (58%) |
| Diabetes mellitus | 37 (17%) | 18 (20)% | 11 (16)% |
| Arterial hypertension | 68 (32%) | 28 (30%) | 23 (33%) |
| Previous angina (>4 weeks) | 136 (64%) | 46 (50%)* | 44 (64%) |
| Previous MI | 95 (45%) | 37 (40%) | 30 (43%) |
| Previous coronary revascularisation | 38 (18%) | 9 (10%) | 8 (12)% |
| Congestive heart failure | 24 (11%) | 10 (11%) | 12 (17%) |
| Use of β blockers at admission | 94 (44%) | 38 (41%) | 31 (45%) |
| Use of calcium blockers at admission | 62 (29%) | 16 (17%) | 18 (26%) |
| Use of diuretics at admission | 44 (21%) | 20 (22%) | 18 (26%) |
| Admission ECG | |||
| ST elevation | 9 (4%) | 5 (5%) | 6 (9%) |
| ST depression | 71 (33%) | 39 (42%) | 42 (61%)† |
| T wave inversion | 124 (58%) | 58 (63%) | 44 (64%) |
| Any ST-T change | 153 (72%) | 72 (78%) | 54 (78%) |
| Median (IQR) time from qualifying pain episode to inclusion (hours) | 12 (6–18) | 14 (19–9) | 13 (8–19) |
| Study drug (inogatran) | 162 (76%) | 67 (73%) | 57 (83%) |